Tenoxicam versus lynestrenol-ethinyl estradiol treatment of dysfunctional uterine bleeding cases during adolescence

Journal of Pediatric and Adolescent Gynecology

Volumn 11, Issue 4, 1998, Pages 177-180

  Creatsas, G ^a   Cardamakis, E ^a   Deligeoroglou, E ^a   Hassan, E ^a   Tzingounis, V ^a  

^a NONE   (Greece)

Author keywords

Dysfunctional uterine bleeding; Lynestrenol ethinyl estradiol; Menorrhagia; Tenoxicam

Indexed keywords

ETHINYLESTRADIOL PLUS LYNESTRENOL; HEMOGLOBIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; TENOXICAM;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CURETTAGE; DRUG EFFICACY; FEMALE; HEMATOCRIT; HOSPITALIZATION; HUMAN; MENORRHAGIA; MENSTRUATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; UTERUS BLEEDING;

EID: 0031765437     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-3188(98)70138-X     Document Type: Article

References (19)

1. S.P. Hertweck Dysfunctional uterine bleeding Obstet Gynecol Clin North Am 19 1992 129
2. American College of Gynecology: Dysfunctional uterine bleeding. 1989.(Technical Bulletin 134).
3. V. Dramusic H.H. Goh M. Yang Menstrual dysfunctions in adolescence Sing J Obstet Gynaecol 22 1991 69
4. 2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives Eur J Obstet Gynecol ReprodBiol 36 1990 292
5. C.J. Dockeray The use of prostaglandins synthetase inhibitors in dysfunctional uterine bleeding R.W. Shaw Advances in Reproductive Endocrinology: Dysfunctional Uterine Bleeding. 1990 Parthenon Publishing Group Casterton Hall, Carnforth, UK p117
6. Stamatopoulos P, Tsalikis T, Pantos G, et al.: The use of a prostaglandin inhibitor—mefenamic acid—in the treatment of adolescent menorrhagia.
7. H. Fenner Pharmacology of tenoxicam H. Fenner Tenoxicam: A New Nonsteroidal Anti-Inflammatory Drug. 1987 Eular Basel, Switzerland p13
8. E.A. Willman W.P. Collins S.G. Clayton Studies in the involvement of prostaglandins in uterine symptomatology and pathology Br J Obstet Gynaecol 88 1976 337
9. G. Creatsas N. Goumalatsos N. Eleftheriou Dysfunctional uterine bleeding during adolescence Proceedings of the Fourth Annual European Congress on Pediatric and Adolescent Gynecology 1988 Athens, Greece, Entopia Center of Publishing Application, Ltd 1988 324
10. J. Milsons K. Andersson B. Andersch A comparison of flubiprofen, transexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia Am J Obstet Gynecol 164 1991 879
11. 2) in excessive menstrual bleeding Lancet 1 1981 522
12. M.A. Van Eijkeren G.C.M.L. Christiaens H.J. Geure Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia Am J Obstet Gynecol 166 1992 1419
13. 2 binding sites and their profiles during the menstrual cycle and in pathologic states Am J Obstet Gynecol 151 1985 369
14. G.E. Hofmann Rao ChV G.H. Barrows Topography of human uterine prostaglandin E and trace receptors their profiles during pathologic states J Clin Endocrinol Metab 57 1983 360
15. I.S. Fraser C. Pearse R.P. Shearman Efficiency of mefenamic acid in patients with a complaint of menorrhagia Obstet Gynecol 58 1981 543
16. C.J. Dockeray B.L. Sheppard J. Bonnar Comparison between mefenamic acid and danazol in the treatment of established menorrhagia Br J Obstet Gynaecol 96 1989 840
17. W.Y. Chan Prostaglandins and nonsteroidal anti-inflammatory drugs in dysmenorrhoea Ann Rev Pharma col Toxicol 23 1983 131
18. M.C.P. Rees R. Canefe-Soler A.L. Bernat Effect of fenamates on prostaglandin receptor binding: preliminary communication Lancet 1 1988 541
19. A. Boctor M. Eickholt I.A. Pugsley Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro Prostaglandins Leukot Med 1986 229